This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA is a proud sponsor of the event.
Cecile Matthews and Bhavesh Patel present the session titled “Indication sequencing – how best to ‘play the game'”
Session summary: With the core objective of revenue maximization across the lifecycle of multi-indication products, different impact factors and considerations for pricing and access using a structure framework of what will inform the optimal indication sequence will be explored.
For more information on this event, click here.
Navigating payer challenges for rare disease treatments requires innovative approaches to evidence generation and pricing strategies. Our Life Sciences...
Access to medicine and healthcare services poses persistent challenges, especially in low-income regions with high out-of-pocket expenses. Pharmaceutical...
CRA is exhibiting at the conference at booth #2018. Matt Majewski presents his session titled “What is a Fair Price for a Rare Disease Therapy?”...
HBA New York Tri-State presents an engaging evening continuing the discussion of the intersection of Health Equity & Women’s Global Health. How chronic pain...
